Fatigue, a common complaint in clinical practice, is often an enigmatic condition to diagnose and manage. Its multifactorial nature makes it a challenging symptom to address, necessitating an all-encompassing approach from healthcare professionals.
Fatigue is a subjective sensation of weariness, weakness, or lack of energy. It can be a symptom of an underlying physical or mental health condition, or it can exist independently. It is vital to differentiate between normal fatigue, which is temporary and relieved by rest, and pathological fatigue, which is persistent and not necessarily related to exertion or alleviated by rest.
A comprehensive history and physical examination form the cornerstone of the diagnostic approach. It is crucial to ascertain the duration, onset, pattern, and associated symptoms of fatigue. Physical examination should focus on identifying signs of systemic disease. Laboratory tests should be tailored to individual patients based on their history and physical examination findings.
The management of fatigue is primarily directed towards treating the underlying cause, if identified. In cases where no specific cause is found, the treatment focuses on symptom relief. Cognitive-behavioral therapy and graded exercise therapy have been shown to be effective in managing chronic fatigue syndrome. Pharmacological interventions can be considered based on the patient's symptoms and overall health status.
Healthcare professionals should educate patients about the importance of maintaining a healthy lifestyle, including regular physical activity, adequate sleep, and balanced nutrition. Patients should also be informed about the potential benefits and risks of different treatment options.
In conclusion, fatigue is a complex symptom that requires a comprehensive clinical approach. A thorough understanding of its potential causes, coupled with a patient-centered approach to diagnosis and management, can help healthcare professionals effectively address this pervasive issue.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation